Publications by authors named "S Aoufouchi"

Article Synopsis
  • * Its overexpression is particularly linked to CLL cases with unmutated immunoglobulin heavy chain variable (IGHV) genes, causing significant DNA damage and contributing to a more aggressive disease.
  • * The review emphasizes c-MYC's dual role in promoting rapid cell proliferation and driving genetic recombination, suggesting it could be a promising target for new therapeutic strategies in CLL.
View Article and Find Full Text PDF

Chronic lymphocytic leukemia (CLL) is an incurable indolent non-Hodgkin lymphoma characterized by tumor B cells that weakly express a B-cell receptor. The mutational status of the variable region (IGHV) within the immunoglobulin heavy chain (IGH) locus is an important prognosis indicator and raises the question of the CLL cell of origin. Mutated IGHV gene CLL are genetically imprinted by activation-induced cytidine deaminase (AID).

View Article and Find Full Text PDF

Background: Clinical studies have highlighted the efficacy of anti-programmed death 1 (αPD-1) monoclonal antibodies in patients with DNA mismatch repair-deficient (MMRD) tumors. However, the responsiveness of MMRD cancers to αPD-1 therapy is highly heterogeneous, and the origins of this variability remain not fully understood.

Methods: 4T1 and CT26 mouse tumor cell lines were inactivated for the MMRD gene leading to a massive accumulation of mutations after serial passages of cells.

View Article and Find Full Text PDF

Somatic hypermutation (SHM) of immunoglobulin (Ig) genes is a B cell specific process required for the generation of specific and high affinity antibodies during the maturation of the immune response against foreign antigens. This process depends on the activity of both activation-induced cytidine deaminase (AID) and several DNA repair factors. AID-dependent SHM creates the full spectrum of mutations in Ig variable (V) regions equally distributed at G/C and A/T bases.

View Article and Find Full Text PDF